1,587
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Medical and cost burden of atherosclerosis among patients treated in routine clinical practice

, , , &
Pages 500-507 | Accepted 02 Jul 2010, Published online: 02 Aug 2010

References

  • Toth PP. Subclinical atherosclerosis: what it is, what it means and what we can do about it. Int J Clin Pract 2008;62:1246-1254
  • American Heart Association. Heart Disease and Stroke Statistics: 2007 Update. Dallas, TX. American Heart Association, 2007
  • Coronary Heart Statistics 2008: United Kingdom. Available athttp://www.ws3.heartstats.web.baigent.net/datapage.asp?id=7998 [Accessed October 2009]
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383
  • Bakhai A. The burden of coronary, cerebrovascular and peripheral arterial disease. Pharmacoecon 2004;22(Suppl 4):11-18
  • Leys D. Atherothrombosis: a major health burden. Cerebrovasc Dis 2001;11(Suppl 2):1-4
  • Mahoney EM, Wang K, Cohen DJ, et al. One-year costs in patients with a history of or at risk from atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes 2008;1:38-45
  • Steg PG, Bhatt DL, Wilson PWF, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007;297:1197-1206
  • Gandra SR, Lawrence LW, Parasuraman BM, et al. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease. J Manag Care Pharm 2006;12:546-554
  • Mody R, Kalsekar I, Kavookjian J, et al. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes. J Diabetes Complications 2007;21:75-83
  • Blanchette CM, Gutierrez B, Ory C, et al. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. J Manag Care Pharm 2008;14:176-185
  • Harley C, Li H, Corey-Lisle P, et al. Influence of medication choice and comorbid diabetes: the cost of bipolar disorder in a privately insured US population. Soc Psychiatr Epidemiol 2007;42:690-697
  • Etemad LR, McCollam PL. Total first-year costs of acute coronary syndrome in a managed care setting. J Manag Care Pharm 2005;11:300-306
  • Margolis J, Barron JJ, Grochulski D. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data. J Manag Care Pharm 2005;11:727-734
  • Kiechl S, Willeit J, for the Bruneck Study Group. The natural course of atherosclerosis. Part I: incidence and progression. Arterioscler Thromb Vasc Biol 1999;19:1484-1490

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.